Episcleritis is an inflammation of the episclera, the thin layer of tissue that covers the white part of the eye (the sclera). It is a relatively uncommon condition, with an estimated incidence of 5-10 cases per 100,000 people per year. Episcleritis is usually a benign condition, although it can be painful and may cause redness and discomfort in the affected eye. It is important for doctors to be aware of the signs and symptoms of episcleritis in order to diagnose and treat the condition quickly and effectively.
The exact cause of episcleritis is not known. However, it is believed to be related to an underlying inflammatory process. It has been associated with autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and Sjogren’s syndrome. In some cases, it may be caused by an infection or an allergy.
The most common symptom of episcleritis is redness of the affected eye. The redness may be localized to the area around the eye or may spread across the entire surface of the eye. Other symptoms may include itching, tearing, pain, and sensitivity to light. In some cases, the affected eye may become swollen or have a gritty feeling.
The diagnosis of episcleritis is usually based on a physical examination and the patient’s symptoms. The doctor may also perform a slit-lamp examination, which is an examination of the eye using a special microscope. This allows the doctor to look for signs of inflammation in the episclera. In some cases, the doctor may also perform tests to rule out other conditions, such as an infection or an allergy.
The treatment of episcleritis depends on the underlying cause. In most cases, the condition resolves on its own without treatment. However, if the condition is severe or does not improve with time, the doctor may prescribe medications to reduce inflammation and pain. These medications may include corticosteroids, anti-inflammatory drugs, or antibiotics. In some cases, the doctor may also recommend using artificial tears to reduce discomfort.
The best way to prevent episcleritis is to avoid triggers that may lead to inflammation. These triggers may include allergens, infections, and certain medications. It is also important to practice good hygiene, such as washing the hands regularly and avoiding contact with people who have an infection.
Episcleritis is an inflammation of the episclera, the thin layer of tissue that covers the white part of the eye (the sclera). It is usually a benign condition, although it can be painful and may cause redness and discomfort in the affected eye. It is important for doctors to be aware of the signs and symptoms of episcleritis in order to diagnose and treat the condition quickly and effectively. Treatment of episcleritis depends on the underlying cause, and may include medications to reduce inflammation and pain. The best way to prevent episcleritis is to avoid triggers that may lead to inflammation.
1.
"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.
2.
Recently released national data on drug use and abuse among Americans.
3.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Personalized Tumor Ecological Landscapes in Oncology
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Preserving Social Identity During Cancer Survivorship
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Regenerative Models of Tumor Microenvironments: Clinical Relevance and Emerging Insights
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
From Guidelines to Practice: Hematology
5.
Breast Cancer Awareness and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation